Company Filing History:
Years Active: 2023
Title: The Innovations of Johan Irma H Vandersmissen
Introduction
Johan Irma H Vandersmissen, a remarkable inventor based in Hoeselt, Belgium, has made significant contributions to the field of epigenetics. With a strong focus on advancing scientific methods, Vandersmissen's work showcases the blend of innovation and practical application in modern science.
Latest Patents
One of Vandersmissen's notable patents is titled "PCR-based epigenetic age prediction." This innovative method involves generating an epigenetic age prediction through a comprehensive approach. It includes providing a sample extraction test kit and receiving a sample extracted using this kit. The subsequent steps involve extracting DNA from the sample, processing it to yield amplified DNA, and ultimately determining a range of methylation values for various CpG sites. This patent illustrates Vandersmissen's contribution to enhancing age prediction methodologies within the field of genetics.
Career Highlights
Vandersmissen's career at H42, Inc. is marked by his dedication to research and innovation. His work has been instrumental in developing novel techniques for analyzing epigenetic markers, thereby contributing to the understanding of biological aging. The implications of his research extend beyond theoretical knowledge, providing practical tools for medical and scientific applications.
Collaborations
Throughout his career, Vandersmissen has collaborated with several professionals in his field, including colleagues Sandra Ann R Steyaert and Geert Trooskens. These collaborations have fostered a creative environment that promotes innovative thinking and enhances the quality of research output.
Conclusion
In summary, Johan Irma H Vandersmissen stands out as an inventive force in the realm of epigenetics. His pioneering patent and collaborative efforts at H42, Inc. highlight the importance of innovation in scientific research. Vandersmissen's contributions not only advance our understanding of biological processes but also pave the way for future breakthroughs in genetic studies.